The competition regulator in Britain has stated that the acquisition of Thales’ signaling business by Hitachi, which costs 1.7 billion euros ($1.8 billion), has the potential to increase the expenses associated with upgrading the country’s rail network. To address this issue, the regulator has requested that the companies provide a response.
The Competition and Markets Authority (CMA) identified Hitachi Rail and Thales SA’s Ground Transportation business as major suppliers of railway signaling systems, along with Siemens and Alstom, for both mainline and urban networks.
Read more: Hitachi-Thales Deal Referred To UK Antitrust Regulator
“We have provisionally found that, should the merger go ahead, it would reduce the number of signaling suppliers in what is already a highly concentrated industry, and the resulting loss of competition could leave transport networks and passengers worse off,” the CMA said on Thursday, reported Reuters.
“We will now consult on our findings and on how Hitachi and Thales might address our concerns, in a way that protects passengers and delivers the government’s objective for a more reliable, efficient and modern railway.”
Hitachi Rail expressed their disappointment with the CMA’s provisional findings and stated that they will carefully assess how to address the concerns raised.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI